Receipt of opioid agonist treatment halves the risk of HIV-1 RNA viral load rebound through improved ART adherence for HIV-infected women who use illicit drugs-Reference-Cited by-同舟云学术

Receipt of opioid agonist treatment halves the risk of HIV-1 RNA viral load rebound through improved ART adherence for HIV-infected women who use illicit drugs

Published:2020-01 Issue: Volume:206 Page:107670
ISSN:0376-8716
Container-title:Drug and Alcohol Dependence
language:en
Short-container-title:Drug and Alcohol Dependence

Author:

Adams Joëlla W.,Marshall Brandon D.L.^ORCID,Mohd Salleh Nur Afiqah,Barrios Rolando,Nolan Seonaid,Milloy M.-J.^ORCID

Funder

National Institutes of Health

Canadian Institutes of Health Research

Michael Smith Foundation for Health Research

Publisher

Elsevier BV

Subject

Pharmacology (medical),Psychiatry and Mental health,Pharmacology,Toxicology

Reference53 articles.

1. Postpartum engagement in HIV care: an important predictor of long-term retention in care and viral suppression;Adams;Clin. Infect. Dis.,2015

2. Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine;Bachireddy;Drug Alcohol Depend.,2014

3. Acute and chronic effects of cocaine on the immune system and the possible link to AIDS;Baldwin;J. Neuroimmunol.,1998

4. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations;Baron;J. Pers. Soc. Psychol.,1986

5. Directly observed antiretroviral therapy improves adherence and viral load in drug users attending methadone maintenance clinics: a randomized controlled trial;Berg;Drug Alcohol Depend.,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV status and substance use disorder treatment need and utilization among adults in the United States, 2015–2019: Implications for healthcare service provision and integration;Journal of Substance Use and Addiction Treatment;2024-09

2. Considerations when prescribing opioid agonist therapies for people living with HIV;Expert Review of Clinical Pharmacology;2024-07-02

3. NeuroHIV in the context of opioid use disorder;HIV-Associated Neurocognitive Disorders;2024

4. Overamped: Stimulant Use and HIV Pathogenesis;Current HIV/AIDS Reports;2023-11-16

5. Population-level prevalence of detectable HIV viremia in people who inject drugs (PWID) in Ukraine: Implications for HIV treatment and case finding interventions;PLOS ONE;2023-10-26